SCHEMBL4948679

SCHEMBL4948679

O=C(COc1cccc(Br)c1)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
GAA P10253 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTR1A P08908 2/20 0.41
HTR2A P28223 2/20 0.41
HTR7 P34969 2/20 0.41
HTR6 P50406 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
RECQL P46063 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR183 P32249 1/20 0.41
FKBP1A P62942 1/20 0.41
PDK2 Q15119 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953715 0.89 MAPT (0.54) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4951646 0.88 MEN1 (0.58) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4948828 0.88 ENPP2 (0.49) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4952809 0.88 GAA (0.57) MEN1KMT2AGAAHTR7RECQL
SCHEMBL4952558 0.88 FKBP1A (0.56) MEN1KMT2AHTR1AHTR2AHTR7
SCHEMBL13996727 0.86 RECQL (0.44) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL13996616 0.86 MEN1 (0.43) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4955662 0.85 NPC1 (0.60) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4948674 0.85 L3MBTL1 (0.45) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL4953381 0.85 ALDH1A1 (0.56) MEN1KMT2AGAARECQLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 MEN1 2976/4885KMT2A 4099/4885OPRM1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.